Merck: A Speed Bump For Keytruda? By: Stocks to Watch June 13, 2017 at 09:18 AM EDT Shares of Merck are falling after the drug maker paused two enrollment in two big studies testing its cancer drug Keytruda as a treatment for multiple myleoma. Read More >>